Sephadex (bead form, Pharmacia). The developing buffer (0.2 M ammonium acetate, pH 4.6) was allowed to flow by gravity through the column at a flow rate of 48 ml/hr. Fractions were collected at 8-min intervals. Column and gel preparation, fraction analysis, and starch gel electrophoresis were performed as previously described.7 Amino acid analysis was done with a Technicon amino acid analyzer (Technicon Inc., Chauncey, N. Y.). Performic acid oxidation was carried out as described by Moore.8 The N-terminal amino acid was determined by the methods of Sanger,9 and by the Konigsberg and Hill modification of the Edman procedure.'0 Tryptophan was measured by the method of Goodwin Figure 1 . Gel filtration of 500 mg of the TCA product on Sephadex G-75 led to the elution pattern illustrated in Figure 2 . Table  0l 1. From these data, a tentative em-0.6 pirical formula was calculated: Lys8, The presence of a free sulfhydryl group contained the major portion of the biological could not be detected by amperome-activity. tric titration at pH 7.0 in the presence or absence of 7 M urea. However, the amino acid analyses of both the native and performic acid-oxidized peptide (Table  1) to the next. There remains the fact that, by the method of Konigsberg and Hill,1I a lysine as well as a threonine residue was lost during cyclization and hydrolysis. However, in view of the fact that the epsilon-amino group of lysine reacts with the Edman reagent and that complete regeneration of free lysine is not always obtained,'0 the presence of a single N-terminal threonine is highly probable.
Of particular interest is the finding of a single half-cystine residue or, after performic acid oxidation, a single cysteic acid residue. This led naturally to the attempt to demonstrate a free sulfhydryl group. However, it was not possible to do so even if the peptide was dissolved in 7 M urea. Three alternatives appear possible: either (1) the SH group is present but becomes oxidized rapidly; (2) the sulfur atom of the cysteine residue is in a thioester linkage or thiazoline ring structure; or (3) the cysteine is linked to a mercaptan in an S-S linkage similar to that recently found in the protease from streptococci.'6 The first possibility is made unlikely by the fact that incubation of the peptide with N-ethylmaleimide at pH 6.0 under nitrogen did not lead to any change in biological activity. The other two possibilities are being investigated.
Thyrocalcitonin is highly active biologically in that 50 m/Ag/min infused into a 100-gm rat led to a significant (1 mg/100 ml) decrease in the concentration of the plasma calcium within 60 min. In addition to lowering the concentration of the plasma calcium, infusion of the purified material also led to a fall in the concentration of the plasma phosphate. A similar fall in plasma phosphate has been observed after the administration of crude extracts of porcine thyroid tissue.4 The terms in the column headings are the intervals of hydrolysis. The column headed '22 Hr oxidized" is the analysis of the performic acid-oxidized sample. The residues recorded in the column headed "Calculated" represent values corrected by extrapolation to 0 time. The final column represents the amino acid analysis of the peptide carried through one Edman degradation cycle.
The availability of a homogeneous preparation of thyrocalcitonin now makes possible a systematic investigation of its mode of action and an immunochemical approach to its measurement in biologic fluids. Hopefully, such studies will lead to a better understanding of the role of this agent in calcium homeostasis.
Summary.-The isolation and characterization of thyrocalcitonin from porcine thyroid tissue is described. The hormone is a polypeptide with a molecular weight of 8,700, a single N-terminal threonine, and contains a single cysteine residue in an unusual but as yet unidentified form.
